XJPX7780
Market cap677mUSD
Jan 17, Last price
1,396.00JPY
1D
-0.07%
1Q
-9.41%
Jan 2017
69.47%
IPO
115.60%
Name
Menicon Co Ltd
Chart & Performance
Profile
Menicon Co., Ltd. manufactures and sells contact lenses and lens care products. The company offers its products to hospitals, ophthalmology clinics, contact lens stores, eyeglass stores, and drug stores. It exports its products in 80 countries, including the United States, Europe, Oceania, and Asia. Menicon Co., Ltd. was incorporated in 1943 and is headquartered in Nagoya, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 116,192,000 5.44% | 110,194,000 10.00% | 100,172,000 16.20% | |||||||
Cost of revenue | 60,244,000 | 56,044,000 | 51,235,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 55,948,000 | 54,150,000 | 48,937,000 | |||||||
NOPBT Margin | 48.15% | 49.14% | 48.85% | |||||||
Operating Taxes | 2,573,000 | 4,138,000 | 3,418,000 | |||||||
Tax Rate | 4.60% | 7.64% | 6.98% | |||||||
NOPAT | 53,375,000 | 50,012,000 | 45,519,000 | |||||||
Net income | 4,538,000 -38.48% | 7,377,000 13.83% | 6,481,000 8.89% | |||||||
Dividends | (1,901,000) | (1,519,000) | (1,321,000) | |||||||
Dividend yield | 1.45% | 0.66% | 0.55% | |||||||
Proceeds from repurchase of equity | 256,000 | 13,145,000 | (372,000) | |||||||
BB yield | -0.20% | -5.68% | 0.15% | |||||||
Debt | ||||||||||
Debt current | 26,214,000 | 3,641,000 | 4,799,000 | |||||||
Long-term debt | 49,849,000 | 55,805,000 | 44,685,000 | |||||||
Deferred revenue | 1,000 | 2,067,000 | 2,146,000 | |||||||
Other long-term liabilities | 2,342,000 | 244,000 | 471,000 | |||||||
Net debt | 28,432,000 | 14,521,000 | 13,170,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 11,866,000 | 12,749,000 | 12,719,000 | |||||||
CAPEX | (21,334,000) | (12,975,000) | (15,946,000) | |||||||
Cash from investing activities | (21,575,000) | (13,776,000) | (16,149,000) | |||||||
Cash from financing activities | 14,554,000 | 8,900,000 | (5,402,000) | |||||||
FCF | 34,429,000 | 39,838,000 | 33,334,000 | |||||||
Balance | ||||||||||
Cash | 46,911,000 | 41,285,000 | 33,046,000 | |||||||
Long term investments | 720,000 | 3,640,000 | 3,268,000 | |||||||
Excess cash | 41,821,400 | 39,415,300 | 31,305,400 | |||||||
Stockholders' equity | 66,339,000 | 138,277,000 | 124,806,000 | |||||||
Invested Capital | 113,115,600 | 89,631,700 | 79,131,600 | |||||||
ROIC | 52.65% | 59.27% | 62.38% | |||||||
ROCE | 35.87% | 41.56% | 43.92% | |||||||
EV | ||||||||||
Common stock shares outstanding | 82,713 | 82,432 | 82,267 | |||||||
Price | 1,583.50 -43.59% | 2,807.00 -4.43% | 2,937.00 -10.05% | |||||||
Market cap | 130,975,730 -43.40% | 231,387,477 -4.23% | 241,618,132 -52.02% | |||||||
EV | 159,462,730 | 315,930,477 | 318,520,132 | |||||||
EBITDA | 63,895,000 | 61,598,000 | 56,230,000 | |||||||
EV/EBITDA | 2.50 | 5.13 | 5.66 | |||||||
Interest | 672,000 | 361,000 | 332,000 | |||||||
Interest/NOPBT | 1.20% | 0.67% | 0.68% |